Yue Zhang1, Payal Kapur2,3,4, Jin Ye5, Qing Yuan1, Ananth Madhuranthakam1,6, Ivan Dimitrov7, Yin Xi1, Takeshi Yokoo1,6, Jeffrey Cadeddu1,3, Vitaly Margulis3, Andrea Pavía-Jiménez4,8, James Brugarolas4,8,9, Robert E. Lenkinski1,6, and Ivan Pedrosa1,4,6
1Radiology, UT Southwestern Medical Center, Dallas, TX, United States, 2Pathology, UT Southwestern Medical Center, Dallas, TX, United States, 3Urology, UT Southwestern Medical Center, Dallas, TX, United States, 4Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States, 5Molecular Genetics, UT Southwestern Medical Center, Dallas, TX, United States, 6Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX, United States, 7Philips Medical Systems, Cleveland, OH, United States, 8Internal Medicine, UT Southwestern Medical Center, Dallas, TX, United States, 9Developmental Biology, UT Southwestern Medical Center, Dallas, TX, United States
Synopsis
We
investigated the correlation between in
vivo fat fraction (FF) measurements by Dixon-based MRI in clear cell renal
cell carcinoma (ccRCC) and both intracellular fat accumulation at
histopathology and lipidomic profile in the same tumor by mass spectrometry.
Quantitative targeted fat fraction measures were obtained from representative
areas within each tumor and correlated with the percentage of cells containing
fat in fresh tissue samples from the same location of the tumor. Lipidomic
analysis of additional tissue samples was performed. Quantitative FF measures
correlated with lipid accumulation in ccRCC and provide a tool for assessing
heterogeneous metabolic pathways in these tumors.INTRODUCTION
The Tumor Cancer Genome Atlas
(TCGA) analysis of gene and protein expression has confirmed major alterations
in glucose, amino acid and lipid metabolism in clear cell renal cell carcinoma
(ccRCC), the most common type of RCC, which is characterized by histologically
prominent storage of glycogen and lipids (1). ccRCC expresses high levels of
enzymes necessary to produce fatty acids and other lipids, and two of these, fatty
acid synthase (FAS) and stearoyl-CoA desaturase (SCD1), are associated with
poor prognosis (2,3). These observations strongly suggest that reprogrammed lipid
metabolism in ccRCC might provide not only biomarkers of oncological
aggression, but perhaps therapeutic targets as well. Thus, exploring
non-invasive MRI methods as predictive metabolic biomarkers in ccRCC is
appealing. However, ccRCC is characterized by intratumoral molecular
heterogeneity (4), which likely drives the biological behavior of this disease.
Moreover, to our knowledge, the heterogeneity of lipid accumulation in ccRCC has
not been previously studied. The purpose of this study was to assess
intratumoral heterogeneity of lipid accumulation in ccRCC
in vivo and to correlate MRI-based fat fraction measures with lipid accumulation at histopathology and the lipidomic profile in the same tumor.
MATERIALS
AND METHODS
Patients
and MRI Protocol:
This was a prospective, IRB-approved, HIPAA-compliant study. 36 patients with
pathologically confirmed ccRCC (after nephrectomy) signed informed consent and underwent
3T dual-transmit MRI with a 16-channel SENSE-XL-Torso coil (n=23, Achieva; n=13,
Ingenia, Philips Healthcare, Best, the Netherlands). Axial and coronal
T2-weighted single-shot turbo spin-echo images (T2WI) were acquired to localize
the tumor followed by axial breath-held three-dimensional (3D) T1-weighted
(T1W) fast field-echo (FFE) multi-echo DIXON (mDIXON)(TR/TE = 6.7~8/1.09~1.24
ms, ΔTE = 0.9~1.1ms, 6 echoes, FA = 2~3°, NSA = 1, thickness = 3mm, in-plane
resolution = 1.5mm×2mm, acquisition FOV = 402×240×96 mm2,
acquisition matrix = 268×120×32, bandwidth = 1413.2 Hz/pixel, acquisition time=
15~19 seconds).
Image Analysis:
Fat fraction (FF) maps were reconstructed based on a 7-peak spectral modeling
(5). Using a DICOM viewer (OsiriX), up to 8 (4 for small lesions) random regions
of interest (rROIs) were placed within each tumor on the FF map to assess tumor
heterogeneity; half in a superior slice and the other half in an inferior slice
through the mass. In addition,
targeted ROIs
(tROIs) were placed on representative locations of the tumor including an area
with high lipid content (when present) on the FF map.
Histopathology: After partial (n=23), radical (n=12) or simple
(n=1) nephrectomy, tumor specimens were anatomically oriented with the use of
fiducial markers placed during surgery and then bivalded through the center to
match the location of the MRI acquisitions. Tumor slides were obtained from the
selected cutting location and stained with hematoxylin-eosin for assessment of
nuclear (Fuhrman) tumor grade. A total of 17 fresh tumor samples matching the
location of at least one tROI were obtained from 14 patients (2 samples from
one patient, 3 samples from one patient) and stained with Oil Red O. The percentage
of cells that stained with Oil Red O was estimated visually to the nearest
percentage by a uropathologist who was blinded to the FF results. Additional
fresh tissue samples matching tROIs were used for lipidomic analysis with gas chromatography-electron
capture negative ionization-mass spectrometry.
Statistics: Mean FF and standard deviation (SD) for rROIs
were correlated to tumor grade. Spearman correlation and linear regression
model were used to assess the relationship between FF, Oil Red O percentage and
lipidomic results (
P<0.05
considered statistically significant).
RESULTS
Fig.1 shows representative
images of one tumor and placement of 8 rROIs. We found heterogeneous lipid
accumulation both among different tumor grades and within each tumor (
Fig.2). Levels of lipid accumulation
and heterogeneity (SD) were not correlated with tumor grade or size (
P>0.05). FF measures in tROIs
correlated statistically with Oil Red O percentage (
ρ=0.90,
P<0.0001) (
Fig.3).
Fig. 4 shows representative images in a tumor with low fat content
and a tumor with high fat content, tROI in each tumor, and correlative Oil Red
O stain in the same location of the tumor. FF measures correlated positively with
increased triglycerides (TG) (
P=0.0007) and free cholesterol (
P=0.006) counts in lipidomic analysis of fresh tissue samples in the same
location of the tumor.
DISCUSION
Dixon-based MRI offers an opportunity to characterize renal
tumors
in vivo based on lipid
accumulation. Furthermore, Dixon-based MRI-directed targeted tissue sampling
provides a platform for understanding intratumoral heterogeneity in lipid
metabolism that may be leveraged to identify potential therapeutic targets.
CONCLUSION
Quantitative Dixon-based
MRI allows for noninvasive assessment of intratumoral heterogeneity of lipid
metabolism in ccRCC.
Acknowledgements
Supported
by Grant NIH/NCI 1R01CA154475.References
1. http://cancergenome.nih.gov/cancersselected/kidneyclearcell
2. Horiguchi A, Asano T, Asano T, et al. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol. 2008 Sep;180(3):1137-40.
3. von Roemeling CA, Marlow LA, Wei JJ, et al. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res. 2013 May 1;19(9):2368-80.
4. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366:883–892.
5. Ren J, Dimitrov I, Sherry D, et al. Composition of
adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla.
Journal of Lipid
Research, 2008, 49: 2055-2062.